Literature DB >> 19447929

High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.

Keita Fujikawa1, Atsushi Kawakami, Mami Tamai, Masataka Uetani, Shoichiro Takao, Kazuhiko Arima, Naoki Iwamoto, Toshiyuki Aramaki, Shinya Kawashiri, Kunihiro Ichinose, Makoto Kamachi, Hideki Nakamura, Tomoki Origuchi, Hiroaki Ida, Kiyoshi Aoyagi, Katsumi Eguchi.   

Abstract

OBJECTIVE: To identify the significance of serum cartilage oligomeric matrix protein (COMP), a marker of cartilage turnover, in patients with early-stage rheumatoid arthritis (RA) in relation to other serologic variables and magnetic resonance imaging (MRI) features.
METHODS: Ninety-eight patients with early-stage RA, whose disease duration from onset was less than 2 years, were enrolled. The objective measures at baseline were Disease Activity Score (DAS28), serum C-reactive protein (CRP), serum matrix metalloproteinase-3 (MMP-3), serum antibodies against cyclic citrullinated peptide (anti-CCP), and MRI features of both wrist and finger joints. The MRI features included the number of sites scored positive for synovitis, bone edema, and bone erosion.
RESULTS: Serum COMP concentration was not different among groups identified with low, moderate, and high DAS28-CRP values. However, COMP values were statistically high in subjects positive for bone erosions on MRI compared with the subjects who were negative for bone erosions. A positive correlation of COMP with CRP and with MMP-3 values was also identified.
CONCLUSION: Elevation of COMP may reflect joint damage that is dependent on the synovial inflammatory process in early-stage RA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447929     DOI: 10.3899/jrheum.080926

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.

Authors:  A O El Defrawy; T A Gheita; H M Raslan; M M El Ansary; A H El Awar
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

2.  The degree of cartilage degradation assessed by serum biomarker levels changes after arthroscopic knee synovectomy in rheumatoid arthritis patients.

Authors:  Marina Lipina; Maxim Makarov; Sergey Makarov; Alexander Novikov
Journal:  Int Orthop       Date:  2017-09-09       Impact factor: 3.075

3.  Value of entheseal ultrasonography and serum cartilage oligomeric matrix protein in the preclinical diagnosis of psoriatic arthritis.

Authors:  Hanan Mohamed Farouk; Afaf Abdel Alim Mostafa; Sahar S Youssef; Moataz Mohammed Samy Elbeblawy; Naglaa Youssef Assaf; El Sayed E Elokda
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-03-29

Review 4.  Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.

Authors:  Morten A Karsdal; Thasia Woodworth; Kim Henriksen; Walter P Maksymowych; Harry Genant; Philippe Vergnaud; Claus Christiansen; Tanja Schubert; Per Qvist; Georg Schett; Adam Platt; Anne-Christine Bay-Jensen
Journal:  Arthritis Res Ther       Date:  2011-04-28       Impact factor: 5.156

5.  Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: a cohort study.

Authors:  Emil Rydell; Kristina Forslind; Jan-Åke Nilsson; Magnus Karlsson; Kristina E Åkesson; Lennart T H Jacobsson; Carl Turesson
Journal:  Arthritis Res Ther       Date:  2021-01-14       Impact factor: 5.156

6.  Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis.

Authors:  Mahmood M T M Ally; Bridget Hodkinson; Pieter W A Meyer; Eustasius Musenge; Mohammed Tikly; Ronald Anderson
Journal:  Mediators Inflamm       Date:  2013-04-07       Impact factor: 4.711

7.  The relationship of antibodies to modified citrullinated vimentin and markers of bone and cartilage destruction in rheumatoid arthritis.

Authors:  A S Avdeeva; E N Aleksandrova; A A Novikov; A V Smirnov; M V Cherkasova; E L Nasonov
Journal:  Int J Rheumatol       Date:  2014-04-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.